CASGEVY™ approved for the treatment of patients 12 years of age and older with sickle cell disease (SCD) and transfusion-dependent beta ...

CASGEVY approved for the treatment of patients 12 years of age and older with sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT) in Switzerland and Canada- -45 authorized treat ...

KeyBanc analyst Philip Gibbs maintained a Hold rating on Carpenter Technology (CRS – Research Report) today. The company’s shares closed yesterday at $154.23. According to TipRanks ...

These investigations, launching on SpaceX's 31st Commercial Resupply Services (CRS) mission for NASANational Aeronautics and Space Administration, aim to improve life on Earth through space-based ...

Lupe revealed as much in a new episode of Okayplayer’s show, The Almanac of Rap, sharing CRS’ origin story and where the seemingly defunct group now stands. “It was me rapping over Radiohead ...

Highlights:,Preventative Potential,:,POLB 001,demonstrated,success in reducing cytokine release syndrome (CRS) severity in preclinical models.,Clinical Accessibility ...

What is Pharma 4.0? The term Industry 4.0 refers to the fourth industrial revolution, associated with the application of advanced technologies that have dramatically changed the landscape of ...

Further information can be found at: www.tmepharma.com. TME Pharma® and the TME Pharma logo are registered trademarks.

South Korea’s reputable yet increasingly taxed healthcare industry depends on a robust pharmaceutical sector. As domestic and international demand has increased, the country has further proven ...

State-run Bharat Sanchar Nigam Limited (BSNL) introduced its new logo along with seven services aimed at citizens. The new initiatives focus on security, affordability, and reliability.

SAN RAFAEL, Calif., Nov. 6, 2024 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will present at three upcoming investor conferences. BioMarin ...

TME Pharma will be able to optimize late phase development by selecting the best performing treatment arm against standard of care. The Phase 2 results will serve as a basis for discussions with ...